During an anaphylactic emergency, the audio and visual instructions of Auvi‑Q guide patients through the injection process.
Patients may use the device without waiting for the voice instructions to guide them. Once the injection countdown has begun, however, they should not remove the device from their thigh until the voice prompt says, "Injection complete."
NOTE: Auvi‑Q makes a distinct click and hiss sound when pressed against the outer thigh. This is normal and indicates that Auvi‑Q is working correctly. Patients should be advised not to pull Auvi‑Q away from the leg when they hear the click and hiss sound.
Epinephrine should be administered with caution to patients with hyperthyroidism, diabetes, elderly individuals, pregnant women, patients who have heart disease and patients who are on medications that may sensitize the heart to arrhythmias.
Auvi‑Q™ (epinephrine injection, USP) is indicated in the emergency treatment of allergic reactions (Type I) including anaphylaxis to allergens, idiopathic and exercise-induced anaphylaxis. Auvi‑Q is intended for individuals with a history of anaphylaxis or who are at risk for anaphylactic reactions.
Auvi‑Q should ONLY be injected into the anterolateral aspect of the thigh. DO NOT INJECT INTO BUTTOCK OR INTRAVENOUSLY.
Epinephrine should be administered with caution to patients with certain heart diseases, and in patients who are on medications that may sensitize the heart to arrhythmias, because it may precipitate or aggravate angina pectoris and produce ventricular arrhythmias. Arrhythmias, including fatal ventricular fibrillation, have been reported in patients with underlying cardiac disease or taking cardiac glycosides or diuretics. Patients with certain medical conditions or who take certain medications for allergies, depression, thyroid disorders, diabetes, and hypertension, may be at greater risk for adverse reactions. Adverse reactions to epinephrine include anxiety, apprehensiveness, restlessness, tremor, weakness, dizziness, sweating, palpitations, pallor, nausea and vomiting, headache, and/or respiratory difficulties.
Auvi‑Q is intended for immediate self-administration as emergency supportive therapy only and is not a substitute for immediate medical or hospital care.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see full Prescribing Information.
By clicking on this link, you will be leaving this Sanofi US Web site and going to another, entirely independent, Web site. Sanofi US provides these links as a service to its Web site visitors and users; however, it takes no responsibility for the information on any Web site but its own.
Click the "Continue" button below to go to the page you requested or click "Cancel" to remain on the page.Cancel